Johnston Elected to Medical and Biological Engineering Elite
Professor Keith Johnston was recently inducted Fellow by the American Institute for Medical and Biological Engineering (AIMBE) for his seminal contributions to the utilization of supercritical processes and nanoparticle technologies in drug delivery.
“The 107 inductees consist of some of the most talented and influential members of our field,” said Kenneth Lutchen, AIMBE President and Dean of Engineering at Boston University. “It is both a pleasure and an honor to welcome the Class of 2012 to our College of Fellows.”
The College of Fellows is made up of 1,000 individuals who make up the top 2 percent of medical and biological engineers nationwide. Members are nominated every year by their peers and are considered outstanding bioengineers in academia, industry and the government.
Johnston’s research areas include advanced materials polymers and nanotechnology, biotechnology, energy and environmental engineering. His most recent breakthrough, with the help of Professors Jennifer Maynard and Thomas Truskett, was the introduction of a new physical form of proteins which could potentially address a major drug delivery challenge and revolutionize treatment of cancer, arthritis and infectious disease.
Johnston will attend a formal induction ceremony and reception into the College of Fellows during AIMBE’s 2013 annual event in Washington, D.C.
About the College of Fellows
Since 1991, the College of Fellows has led the way for technological growth and advancement in the fields of medical and biological engineering. Fellows have helped revolutionize medicine and related fields in order to enhance and extend the lives of people all over the world. They have also successfully advocated for public policies that have enabled researchers and business-makers to further the interests of engineers, scientists, and ultimately, patients.
About AIMBE
Representing 50,000 individuals and the top 2% of medical and biological engineers, AIMBE is a non-profit organization headquartered in Washington, D.C. As an advocate for public policy related to improving lives through medical and biological engineering, AIMBE is composed of experts in areas such as clinical practice, industrial practice, and education.